Sensus Healthcare, Inc. (NASDAQ:SRTS)
| Market Cap | $37.20M-43.8% |
| Revenue (ttm) | $16.62M-53.3% |
| Net Income | -$16.04M-433.4% |
| EPS | -$0.97-417.9% |
| Shares Out | 16.46M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 122,016 |
| Open | $2.39 |
| Previous Close | $2.36 |
| Day's Range | $2.19 - $2.41 |
| 52-Week Range | $2.14 - $5.49 |
| Beta | 1.19 |
| Analysts | Buy |
| Price Target | $4.75(+110.18%) |
| Earnings Date | Feb 11, 2027 |
About SRTS
Sensus Healthcare, Inc. operates as a medical technology enterprise, manufacturing and distributing radiation therapy apparatuses to medical institutions across the globe. The company's portfolio leverages superficial radiation therapy (SRT), a cutting-edge low-energy X-ray methodology. Their product line features the SRT-100, a photon X-ray system for low-energy superficial radiotherapy. This device presents a non-surgical alternative for patients dealing with non-melanoma skin cancers, including basal cell and squamous cell carcinomas, alongside other dermatological issues like keloids. Another key offering is the SRT-100 Vision, which incorporates a specialized SRT treatment planning application. This application seamlessly integrates an embedded high-frequency ultrasound imaging module, tools for volumetric tumor analysis, beam margin delineation, and dosimetry parameter configuration. In addition, Sensus Healthcare provides the SRT-100 Plus, the Sentinel service program to ensure system protection for its clients, and options for in-office laser rentals. They also supply various consumable items, such as replacement lead shielding, disposable radiation safety gear like aprons and eye shields, ultrasound probe film, and single-use applicator tips designed to treat lesions of different sizes and on various body areas. Founded in 2010, Sensus Healthcare, Inc. maintains its corporate headquarters in Boca Raton, Florida.
Sensus Healthcare, Inc. Stock Analysis — InsiderScore
Sensus Healthcare, Inc. scored higher than 90% of companies evaluated by InsiderBuying, and ranked 3rd out of 57 stocks in the healthcare sector.
Scores are percentile-ranked against every company we scored that day, with extra weight given to the size and conviction of each purchase and the seniority of the buyer.
Insiders at Sensus Healthcare, Inc. bought $665.3K of stock across 8 purchases in the last 90 days, the largest of them $183.0K.
The average purchase added about 12% to the buyer's existing holding. Doubling a stake earns full marks here; topping up an already large position earns very little.
Every buyer already held stock, so each purchase is an increase rather than a first position.
This category carries 35% of the Insider Score.
What Are Insiders Doing?
View the trades behind this meter — each links to its SEC Form 4 →
Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.
Next catalysts
- Feb 11, 2027Earnings report
$SRTS stock is featured in our Insider Score Rankings, and Insider Trades datasets.
→ All Stock ListsRecently reported changes in SRTS holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by SRTS's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
SRTS Estimated quarterly lobbying spending
Source: U.S. Senate LDA
SRTS Revenue by Segment or Geography
As of: Q3 2026 (Sep 30, 2026) · Source: SEC EDGAR (10-Q)
U.S. Patents
New SRTS patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to SRTS from public contracts
Source: USAspending.gov
Top ETF Holders
ETFs with the largest estimated holdings in SRTS
| VTIVanguard Morningstar Total Stock Market ETF | $1.07M |
| VXFVanguard Extended Market ETF | $426.89K |
| DFASDimensional - US Small Cap ETF | $246.05K |
| DFSVU.S. Small Cap Value Portfolio ETF Class Shares | $174.10K |
| DFACDimensional - US Core Equity 2 ETF | $104.00K |
| IWCiShares Micro-Cap ETF | $99.33K |
Estimated from each fund’s disclosed top holdings × AUM
Bull Case vs Bear Case
AI-generated from SRTS’s recent data — informational, not investment advice
What’s Behind the Score
News check: Q3 2026 earnings with margin expansion and 1,000th system milestone sale signal strong commercial and operational progress for SRTS.
Recent Insider Activity
Insider Score Trend Over Time
+2.7 since Sep 24Composite Insider Score (0–100) recomputed on each scoring run from live SEC Form 4 data.
